Rexahn Pharmaceuticals (REXN) Short Interest Ratio & Short Volume → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free REXN Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock Analysis Rexahn Pharmaceuticals Short Interest DataCurrent Short Volume46,100 sharesPrevious Short Volume22,000 sharesChange Vs. Previous Month+109.55%Dollar Volume Sold Short$83,441.00Short Interest Ratio / Days to Cover0.8Last Record DateDecember 31, 2020Outstanding Shares4,483,000 sharesPercentage of Shares Shorted1.03%Today's Trading Volume2,579 sharesAverage Trading Volume162,968 sharesToday's Volume Vs. Average2% Short Selling Rexahn Pharmaceuticals ? Sign up to receive the latest short interest report for Rexahn Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatREXN Short Interest Over TimeREXN Days to Cover Over TimeREXN Percentage of Float Shorted Over Time Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> Rexahn Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 12/31/202046,100 shares $83,441.00 +109.6%N/A0.8 $1.81 12/15/202022,000 shares $39,820.00 -31.0%N/A0.5 $1.81 11/30/202031,900 shares $57,739.00 +22.2%1.9%0.9 $1.81 11/15/202026,100 shares $47,241.00 +131.0%2.2%0.8 $1.81 10/30/202011,300 shares $24,634.00 +232.4%N/A0.5 $2.18 10/15/20203,400 shares $7,276.00 -75.0%N/A0.1 $2.14 Get the Latest News and Ratings for REXN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Rexahn Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 9/30/202013,600 shares $28,288.00 +353.3%N/A0.3 $2.08 9/15/20203,000 shares $5,850.00 +76.5%N/A0.1 $1.95 8/31/20201,700 shares $3,876.00 -70.7%N/A0 $2.28 8/14/20205,800 shares $14,094.00 -94.3%N/A0.1 $2.43 7/31/2020101,700 shares $270,522.00 +906.9%2.5%1.7 $2.66 7/15/202010,100 shares $27,472.00 -30.3%0.3%0.2 $2.72 6/30/202014,500 shares $40,310.00 +530.4%0.4%0.3 $2.78 6/15/20202,300 shares $6,210.00 +4.6%0.1%0 $2.70 5/29/20202,200 shares $5,412.00 -97.2%0.1%0.1 $2.46 5/15/202078,500 shares $172,700.00 +5.9%2.0%2.8 $2.20 4/30/202074,100 shares $137,826.00 -1.5%1.9%0.2 $1.86 4/15/202075,200 shares $133,856.00 -14.6%1.9%0.2 $1.78 3/31/202088,000 shares $158,400.00 +13.7%2.2%0.2 $1.80 3/13/202077,400 shares $126,162.00 -2.4%1.9%2.8 $1.63 2/28/202079,300 shares $182,390.00 -78.3%2.0%0.2 $2.30 2/14/2020364,900 shares $1.09 million +254.3%9.1%0.9 $3.00 1/31/2020103,000 shares $211,150.00 -0.1%2.6%0.3 $2.05 1/15/2020103,100 shares $231,975.00 -11.0%2.6%1.7 $2.25 12/31/2019115,800 shares $221,178.00 +11.5%2.9%2 $1.91 REXN Short Interest - Frequently Asked Questions What is Rexahn Pharmaceuticals' current short interest? Short interest is the volume of Rexahn Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of December 31st, traders have sold 46,100 shares of REXN short. Learn More on Rexahn Pharmaceuticals' current short interest. What is a good short interest ratio for Rexahn Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. REXN shares currently have a short interest ratio of 1.0. Learn More on Rexahn Pharmaceuticals's short interest ratio. Is Rexahn Pharmaceuticals' short interest increasing or decreasing? Rexahn Pharmaceuticals saw a increase in short interest in December. As of December 31st, there was short interest totaling 46,100 shares, an increase of 109.5% from the previous total of 22,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Rexahn Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Rexahn Pharmaceuticals: Hepion Pharmaceuticals, Inc. (1.19%), Cyclerion Therapeutics, Inc. (1.03%), Virios Therapeutics, Inc. (1.11%), Molecular Templates, Inc. (6.97%), NuCana plc (0.50%), Lixte Biotechnology Holdings, Inc. (4.59%), ASLAN Pharmaceuticals Limited (1.47%), Biofrontera Inc. (1.20%), TFF Pharmaceuticals, Inc. (2.77%), Bionomics Limited (2.03%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($6.95 billion), Aon plc ($4.44 billion), Analog Devices, Inc. ($4.13 billion), Snap Inc. ($3.12 billion), Peloton Interactive, Inc. ($2.68 billion), Moderna, Inc. ($2.60 billion), The Clorox Company ($2.47 billion), The Kroger Co. ($2.32 billion), International Flavors & Fragrances Inc. ($2.21 billion), and Altice USA, Inc. ($1.94 billion). View all of the most shorted stocks. What does it mean to sell short Rexahn Pharmaceuticals stock? Short selling REXN is an investing strategy that aims to generate trading profit from Rexahn Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Rexahn Pharmaceuticals? A short squeeze for Rexahn Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of REXN, which in turn drives the price of the stock up even further. How often is Rexahn Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including REXN, twice per month. The most recent reporting period available is December, 31 2020. More Short Interest Resources from MarketBeat Related Companies: HEPA Short Squeeze CYCN Short Squeeze VIRI Short Squeeze MTEM Short Squeeze NCNA Short Squeeze LIXT Short Squeeze ASLN Short Squeeze BFRI Short Squeeze TFFP Short Squeeze BNOX Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:REXN) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersFed launches fourth dollar overhaulStansberry ResearchJeff Bezos Just Humiliated Elon MuskInvestorPlaceBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press